BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28940863)

  • 1. A phase II study of radioimmunotherapy with intraventricular
    Kramer K; Pandit-Taskar N; Humm JL; Zanzonico PB; Haque S; Dunkel IJ; Wolden SL; Donzelli M; Goldman DA; Lewis JS; Lyashchenko SK; Khakoo Y; Carrasquillo JA; Souweidane MM; Greenfield JP; Lyden D; De Braganca KD; Gilheeney SW; Larson SM; Cheung NV
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28940863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
    Kramer K; Humm JL; Souweidane MM; Zanzonico PB; Dunkel IJ; Gerald WL; Khakoo Y; Yeh SD; Yeung HW; Finn RD; Wolden SL; Larson SM; Cheung NK
    J Clin Oncol; 2007 Dec; 25(34):5465-70. PubMed ID: 18048828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.
    Kramer K; Pandit-Taskar N; Zanzonico P; Wolden SL; Humm JL; DeSelm C; Souweidane MM; Lewis JS; Cheung NK
    J Neurooncol; 2015 Jun; 123(2):245-9. PubMed ID: 25944385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.
    Kramer K; Cheung NK; Humm JL; Dantis E; Finn R; Yeh SJ; Antunes NL; Dunkel IJ; Souwedaine M; Larson SM
    Med Pediatr Oncol; 2000 Dec; 35(6):716-8. PubMed ID: 11107154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.
    Bailey K; Pandit-Taskar N; Humm JL; Zanzonico P; Gilheeney S; Cheung NV; Kramer K
    J Neurooncol; 2019 May; 143(1):101-106. PubMed ID: 30879172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies.
    Kramer K; Smith M; Souweidane MM
    Pediatr Blood Cancer; 2014 Sep; 61(9):1590-2. PubMed ID: 24777835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
    Tringale KR; Wolden SL; Karajannis M; Haque S; Pasquini L; Yildirim O; Rosenblum M; Benhamida JK; Cheung NK; Souweidane M; Basu EM; Pandit-Taskar N; Zanzonico PB; Humm JL; Kramer K
    J Neurooncol; 2023 Mar; 162(1):69-78. PubMed ID: 36853490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and Dosimetry of Intraventricularly Administered
    Pandit-Taskar N; Zanzonico PB; Kramer K; Grkovski M; Fung EK; Shi W; Zhang Z; Lyashchenko SK; Fung AM; Pentlow KS; Carrasquillo JA; Lewis JS; Larson SM; Cheung NV; Humm JL
    J Nucl Med; 2019 Dec; 60(12):1794-1801. PubMed ID: 31405921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates.
    Kramer K; Cheung NK; Humm J; DiResta G; Arbit E; Larson S; Finn R; Rosenblum M; Nguyen H; Gonzalez G; Liu C; Yang YF; Mendelsohn ME; Gillio AP
    J Neurooncol; 1997 Nov; 35(2):101-11. PubMed ID: 9266446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
    Kramer K; Kushner BH; Modak S; Pandit-Taskar N; Smith-Jones P; Zanzonico P; Humm JL; Xu H; Wolden SL; Souweidane MM; Larson SM; Cheung NK
    J Neurooncol; 2010 May; 97(3):409-18. PubMed ID: 19890606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
    Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
    Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.
    Kramer K; Donzelli MA; Pessin MS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2411-2414. PubMed ID: 33533945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 study of intraventricular
    Kramer K; Pandit-Taskar N; Kushner BH; Zanzonico P; Humm JL; Tomlinson U; Donzelli M; Wolden SL; Haque S; Dunkel I; Souweidane MM; Greenfield JP; Tickoo S; Lewis JS; Lyashchenko SK; Carrasquillo JA; Chu B; Horan C; Larson SM; Cheung NV; Modak S
    J Hematol Oncol; 2022 Nov; 15(1):165. PubMed ID: 36371226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing successful cerebrospinal fluid flow for radioimmunotherapy.
    Kramer K; McCrea HJ; Fischer C; Greenfield JP
    J Neurosurg Pediatr; 2012 Mar; 9(3):316-9. PubMed ID: 22380961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of myelography on the treatment results for medulloblastoma.
    Deutsch M
    Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):999-1003. PubMed ID: 6746360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.
    Kramer K; Gerald WL; Kushner BH; Larson SM; Hameed M; Cheung NK
    Med Pediatr Oncol; 2001 Jan; 36(1):194-6. PubMed ID: 11464881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Ermani M
    Cancer; 2007 Nov; 110(9):2035-41. PubMed ID: 17823910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelography for staging medulloblastoma.
    Deutsch M; Laurent JP; Cohen ME
    Cancer; 1985 Oct; 56(7 Suppl):1763-6. PubMed ID: 4027907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.